TickerFacts.

Gyre Therapeutics, Inc. (GYRE): EPS (Basic)

Annual figures by period end, from SEC filings.

$0.06
Year ended 2025-12-31
+14.5%
3-year compound annual growth
$0.382009-12-31: -$1.542010-12-31: $0.382011-12-31: -$0.272012-12-31: -$0.212021-12-31: -$2.872022-12-31: $0.042023-12-31: -$1.412024-12-31: $0.142025-12-31: $0.06$0.06
2009-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31$0.06-57.1%2026-03-13, From 2025-01-01
2024-12-31$0.14n/m2026-03-13, From 2024-01-01
2023-12-31-$1.41n/m2025-03-17, From 2023-01-01
2022-12-31$0.04n/m2024-03-27, From 2022-01-01
2021-12-31-$2.87n/a2023-03-30, From 2021-01-01
No annual figure between 2012-12-31 and 2021-12-31.
2012-12-31-$0.21n/m2013-03-15, From 2012-01-01
2011-12-31-$0.27n/m2013-03-15, From 2011-01-01
2010-12-31$0.38n/m2013-03-15, From 2010-01-01
2009-12-31-$1.54n/a2012-03-06, From 2009-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Gyre Therapeutics, Inc. (GYRE)2025-12-31$0.06-57.1%
UroGen Pharma Ltd. (URGN)2025-12-31-$3.19n/m
Xencor Inc (XNCR)2025-12-31-$1.24n/m
Zevra Therapeutics, Inc. (ZVRA)2025-12-31$1.40n/m
Zymeworks Inc. (ZYME)2025-12-31-$1.08n/m
Lifecore Biomedical, Inc. (LFCR)2025-05-25-$1.27n/m
Siga Technologies Inc (SIGA)2025-12-31$0.33-60.2%
Karyopharm Therapeutics Inc. (KPTI)2025-12-31-$17.93n/m
Elite Pharmaceuticals Inc (ELTP)2026-03-31$0.04n/a

Compare GYRE, URGN, XNCR, ZVRA side by side · Screen every company in Pharmaceutical Preparations ↗